LLY

918.96

+0.38%↑

JNJ

238.2

+0.37%↑

ABBV

206.76

-1.17%↓

NVS

147.4

-2.27%↓

AZN

187.84

-0.85%↓

LLY

918.96

+0.38%↑

JNJ

238.2

+0.37%↑

ABBV

206.76

-1.17%↓

NVS

147.4

-2.27%↓

AZN

187.84

-0.85%↓

LLY

918.96

+0.38%↑

JNJ

238.2

+0.37%↑

ABBV

206.76

-1.17%↓

NVS

147.4

-2.27%↓

AZN

187.84

-0.85%↓

LLY

918.96

+0.38%↑

JNJ

238.2

+0.37%↑

ABBV

206.76

-1.17%↓

NVS

147.4

-2.27%↓

AZN

187.84

-0.85%↓

LLY

918.96

+0.38%↑

JNJ

238.2

+0.37%↑

ABBV

206.76

-1.17%↓

NVS

147.4

-2.27%↓

AZN

187.84

-0.85%↓

Search

Quidel Corp

Ouvert

16.26 -8.6

Résumé

Variation du prix de l'action

24h

Actuel

Min

16.3

Max

17.68

Chiffres clés

By Trading Economics

Revenu

602M

-131M

Ventes

24M

724M

Marge bénéficiaire

-18.062

Employés

6,500

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+60.83% upside

Dividendes

By Dow Jones

Prochains Résultats

6 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-172M

1B

Ouverture précédente

24.86

Clôture précédente

16.26

Quidel Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

18 mars 2026, 22:51 UTC

Résultats

AIA Group Value of New Business Rose in 2025, Plans $1.7 Billion New Share Buyback

18 mars 2026, 21:40 UTC

Acquisitions, Fusions, Rachats

Constellation Energy to Sell Portfolio of Assets for $5 Billion to Satisfy Regulators

18 mars 2026, 20:31 UTC

Résultats

Micron 2Q Sales Nearly Triple Amid Tight Memory Supply

18 mars 2026, 23:49 UTC

Market Talk
Principaux Événements d'Actualité

Nikkei May Fall on Renewed Concerns About Higher Energy Prices -- Market Talk

18 mars 2026, 23:31 UTC

Market Talk

Gold Rises on Likely Technical Recovery -- Market Talk

18 mars 2026, 22:49 UTC

Market Talk

New Zealand's Economic Recovery Has Yet to Find Footing -- Market Talk

18 mars 2026, 22:41 UTC

Market Talk

Woodside Energy Opts for 'Safe, Experienced' Choice as CEO -- Market Talk

18 mars 2026, 22:36 UTC

Résultats

AIA Group Value of New Business Rose in 2025, Plans $1.7B New Share Buyback

18 mars 2026, 22:24 UTC

Résultats

AIA Group Announces New Share Buyback of $1.7B >1299.HK

18 mars 2026, 22:23 UTC

Résultats

AIA Group 2025 Value of New Business Margin Was 58.5%, Up 3.6 Ppt on Year >1299.HK

18 mars 2026, 22:23 UTC

Résultats

AIA Group 2025 Value of New Business $5.52B Vs. $4.71B >1299.HK

18 mars 2026, 21:58 UTC

Résultats

Micron Sales Nearly Triple Amid Tight Memory Supply -- Update

18 mars 2026, 21:55 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

18 mars 2026, 21:55 UTC

Market Talk
Résultats

Micron's Phone, PC Business Could Shrink Due to Memory Shortage -- Market Talk

18 mars 2026, 21:40 UTC

Market Talk

Fuel Price Rise Equates to 20 Bps Rate Hike on Australian Households -- Market Talk

18 mars 2026, 21:16 UTC

Market Talk

More Procter & Gamble Alumni Join Strobel at Coty -- Market Talk

18 mars 2026, 21:00 UTC

Principaux Événements d'Actualité

Iran War Puts Pressure on Japan's Economy. Takaichi Is In a Bind. -- Barrons.com

18 mars 2026, 20:58 UTC

Résultats

Micron 2Q Gross Margin Nearly Doubled Due to Higher Pricing, CFO Says

18 mars 2026, 20:41 UTC

Résultats

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 mars 2026, 20:29 UTC

Résultats

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 mars 2026, 20:25 UTC

Résultats

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 mars 2026, 20:17 UTC

Résultats

These Stocks Are Today's Movers: Micron, Swarmer, Lumentum, Trade Desk, Macy's, Williams-Sonoma, and More -- Barrons.com

18 mars 2026, 20:14 UTC

Market Talk

Airlines Can't Offset Higher Fuel Prices for Long -- Market Talk

18 mars 2026, 20:09 UTC

Résultats

Micron Reports Extraordinary Earnings. The Stock Is Up. -- Barrons.com

18 mars 2026, 20:07 UTC

Résultats

Micron Technology Raises Qtr Dividend to 15c Vs. 11.5c >MU

18 mars 2026, 20:06 UTC

Résultats

Micron Technology Board Has Approved 30% Increase in Qtrly Div >MU

18 mars 2026, 20:04 UTC

Résultats

Micron Technology 2Q Operating Cash Flow $11.9 B >MU

18 mars 2026, 20:04 UTC

Résultats

Micron Technology Sees 3Q Operating Expenses About $1.6 B >MU

18 mars 2026, 20:04 UTC

Résultats

Micron Technology Sees 3Q Gross Margin About 81% >MU

18 mars 2026, 20:03 UTC

Résultats

Micron Technology Sees 3Q Adj EPS $19.15 +/- 40c >MU

Comparaison

Variation de prix

Quidel Corp prévision

Objectif de Prix

By TipRanks

60.83% hausse

Prévisions sur 12 Mois

Moyen 30.75 USD  60.83%

Haut 38 USD

Bas 25 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

3

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

Bénéfice d'exploitation

$

À Propos Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat